Cite
Malic Enzyme 2 (ME2) Inhibition in Cancer Therapy: Screening and Validating Compounds with ME2-inhibitory activity
MLA
Demiri, Amina. Malic Enzyme 2 (ME2) Inhibition in Cancer Therapy: Screening and Validating Compounds with ME2-Inhibitory Activity. 2024. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1457627165&authtype=sso&custid=ns315887.
APA
Demiri, A. (2024). Malic Enzyme 2 (ME2) Inhibition in Cancer Therapy: Screening and Validating Compounds with ME2-inhibitory activity.
Chicago
Demiri, Amina. 2024. “Malic Enzyme 2 (ME2) Inhibition in Cancer Therapy: Screening and Validating Compounds with ME2-Inhibitory Activity.” http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1457627165&authtype=sso&custid=ns315887.